Clinical Trials Directory

Trials / Completed

CompletedNCT02250547

Optimization With SonR Method in the ClinicAl pRactice

Status
Completed
Phase
Study type
Observational
Enrollment
278 (estimated)
Sponsor
LivaNova · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Evaluate the percentage of patients optimized at least once every month by the SonR automatic optimization method, until M6 follow-up, in Heart failure (HF) patients prevalently in sinus rhythm

Detailed description

Thanks to the SonR technology it is possible to adjust the optimal VV and AV delays over time, in a fully automatic, time saving and operator independent way. It is possible to optimize the VV and AV delays in office, during follow-up visits, but also enable the automatic optimization that weekly optimize the AV and VV delays. For the reasons mentioned above, the sponsor expects that the SonR optimization method increases the number of patients optimized systematically at each follow-up The purpose of this study is to evaluate the percentage of patients optimized at least once every month by the SonR automatic optimization method, until M6 follow-up, in HF patients prevalently in sinus rhythm. The primary objective will be evaluated as the percentage of patients successfully optimized every month until M6. A patient is considered successfully optimized by the SonR during one month if at least one Atri-Ventricular (AV) or Ventricular-Ventricular (VV) optimization is completed by the SonR automatic optimization method during the month. Patients eligible for the analysis are those with SonR automatic optimization function enabled and at least 50% of the time in sinus rhythm

Conditions

Timeline

Start date
2012-07-01
Primary completion
2017-01-01
Completion
2017-09-01
First posted
2014-09-26
Last updated
2017-11-14

Locations

21 sites across 6 countries: Austria, France, Germany, Italy, Portugal, Spain

Source: ClinicalTrials.gov record NCT02250547. Inclusion in this directory is not an endorsement.